Erythromycin EP Impurity E N-Oxide

N° de SZ CAT:	SZ-E006052
Número CAS	36693-59-1
Mol.F.	C37H65NO13
Peso Molecular	731.9
Status de Fatura	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Nome Químico: (2S,3R,4S,6R)-2-(((2R,3R,4S,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-9-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,4,8,10,12,14-hexamethyl-7-oxo-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-11-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: C[C@]1(OC([C@]([C@H]2O)([H])C)=C(C)C1)[C@]([C@H]([C@]([C@H](C(O[C@H](CC)[C@]2(O)C)=O)C)([H])O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)C)([H])O[C@@](O[C@H](C)C[C@@H]4[N+](C)([O-])C)([H])[C@@H]4O

Isolation and identification of a novel erythromycin-degrading fungus, Curvularia sp. RJJ-5, and its degradation pathway
By Ren, Jianjun; Deng, Liujie; Niu, Dongze; Wang, Zhenzhu; Fan, Bo; Taoli, Huhe; Li, Zhijie; Zhang, Jin; Li, Chunyu
From FEMS Microbiology Letters (2021), 368(1), fnaa215.

Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets
By Jeelani, Salika; Soukhova, Nadejda
From Journal of Pharmaceutical and Biomedical Analysis (2021), 195, 113858

Degradation and mineralization of erythromycin by heterogeneous photocatalysis using SnO2-doped TiO2 structured catalysts: Activity and stability
By Albornoz, L. L.; da Silva, S. W.; Bortolozzi, J. P.; Banus, E. D.; Brussino, P.; Ulla, M. A.; Bernardes, A. M.
From Chemosphere (2021), 268, 128858

Erythromycin EP Impurity E N-Oxide is chemically (2S,3R,4S,6R)-2-(((2R,3R,4S,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-9-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,4,8,10,12,14-hexamethyl-7-oxo-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-11-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide. Erythromycin EP Impurity E N-Oxide is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin EP Impurity E N-Oxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Erythromycin EP Impurity E N-Oxide

Contacts

Our Locations